BioCentury
ARTICLE | Company News

Dyax, Alnis cancer deal

April 15, 2003 7:00 AM UTC

The companies partnered to research and develop therapeutic peptides against an undisclosed cancer target from Alnis (Emeryville, Calif.). DYAX will use its phage display technology to identify and ch...